Missed opportunities for HIV screening in pharmacies and retail clinics

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Pharmacy Practice

Background:

• New recommendations emphasize universal HIV screening (ages 13-64) and immediate treatment (highly active antiretroviral therapy, HAART) for all HIV/AIDS patients.
• Approximately 50,000 new HIV infections occur annually in the US, with many transmitted by unaware individuals.
• Barriers to screening include limited primary care access, high costs, and the need for repeat testing in high-risk groups.

Purpose of the Study:

• To explore the potential of community pharmacies as accessible and affordable venues for expanded HIV screening.
• To identify necessary policy and leadership changes to facilitate pharmacy-based HIV testing.
• To highlight the role of pharmacists in HIV prevention, including risk reduction counseling and linkage to care.

Main Methods:

• The study reviews current HIV screening guidelines and identifies barriers to widespread testing.
• It assesses the feasibility of utilizing community pharmacies and retail clinics within pharmacies for HIV screening.
• It discusses policy and practice adjustments needed to support pharmacy-based HIV testing services.

Main Results:

• Community pharmacies offer accessible and affordable settings for HIV screening.
• Overcoming pharmacist time constraints and establishing reimbursement models are crucial for scalability.
• Pharmacists need training to effectively counsel on risk reduction and connect individuals to care.

Conclusions:

• Community pharmacies are well-positioned to significantly expand HIV screening efforts.
• Policy changes and corporate support are essential to integrate HIV testing into pharmacy practice.
• Empowering pharmacists with training is key to improving HIV testing rates and patient outcomes.